Moderna's stock experienced a 177% increase due to positive news about their personalized cancer vaccine entering stage three trials with Merck.
Source Post
Did Moderna just solve Cancer?
Aug 20, 2026
Moderna's stock surged 177% following news of their cancer vaccine reaching stage three trials in partnership with Merck. While efficacy data is pending, this development is seen as significant for both companies and humanity.
Linked Mentions
Tickers discussed in this post
Merck is mentioned as a partner in Moderna's stage three cancer vaccine trials, a development that has significantly boosted Moderna's stock.
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.